HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Fortina Selected Research

RNA (Ribonucleic Acid)

1/2017Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.
10/2002Pyrosequencing for detection of mutations in the connexin 26 (GJB2) and mitochondrial 12S RNA (MTRNR1) genes associated with hereditary hearing loss.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Fortina Research Topics

Disease

23Neoplasms (Cancer)
01/2022 - 08/2005
9Breast Neoplasms (Breast Cancer)
10/2017 - 11/2009
7Prostatic Neoplasms (Prostate Cancer)
05/2020 - 04/2010
5Leukemia
01/2022 - 08/2015
4Carcinogenesis
04/2015 - 10/2011
3Neuroblastoma
01/2020 - 02/2007
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 01/2018
3Circulating Neoplastic Cells
10/2017 - 01/2016
2Autoimmune Diseases (Autoimmune Disease)
01/2022 - 10/2020
2Neuroinflammatory Diseases
01/2021 - 10/2020
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 10/2020
2Ichthyosis (Xeroderma)
01/2019 - 11/2017
2Aneuploidy (Aneuploid)
04/2015 - 03/2012
2Chromosomal Instability (Chromosome Stability)
04/2015 - 03/2012
2Inflammation (Inflammations)
08/2014 - 06/2010
2Melanoma (Melanoma, Malignant)
12/2013 - 05/2013
2Neoplasm Metastasis (Metastasis)
06/2013 - 12/2006
2beta-Thalassemia (Cooley's Anemia)
10/2008 - 12/2002
2Colorectal Neoplasms (Colorectal Cancer)
04/2007 - 12/2006
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Multiple Sclerosis
01/2022
1Genetic Predisposition to Disease (Genetic Predisposition)
06/2021
1Basal Cell Carcinoma (Rodent Ulcer)
06/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Neutropenia
01/2020
1ST Elevation Myocardial Infarction
12/2019
1Myocardial Infarction
12/2019
1Hodgkin Disease (Hodgkin's Disease)
01/2019
1Epidermodysplasia Verruciformis
01/2019
1Epidermolysis Bullosa
01/2018
1Poikiloderma of Kindler
01/2018
1Acute Coronary Syndrome
01/2018
1Hemorrhage
01/2018
1Philadelphia Chromosome
01/2018
1Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
01/2017
1Disease Progression
09/2016
1Adenocarcinoma
04/2015
1Retinoblastoma (Glioblastoma, Retinal)
11/2014
1Complex Regional Pain Syndromes
08/2014
1Chronic Pain
08/2014

Drug/Important Bio-Agent (IBA)

7DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2002
7Proteins (Proteins, Gene)FDA Link
06/2013 - 12/2008
5Transcription Factors (Transcription Factor)IBA
01/2020 - 04/2010
4Biomarkers (Surrogate Marker)IBA
09/2016 - 11/2014
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022 - 10/2020
3Phosphotransferases (Kinase)IBA
01/2019 - 04/2015
3Cyclin D1IBA
04/2015 - 03/2012
3MicroRNAs (MicroRNA)IBA
08/2014 - 05/2008
3Caveolin 1IBA
09/2011 - 08/2008
2ChromatinIBA
01/2022 - 01/2020
2IntegrinsIBA
05/2020 - 01/2018
2Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2018
2CytokinesIBA
01/2020 - 08/2014
2Estrogen ReceptorsIBA
10/2017 - 09/2011
2RNA (Ribonucleic Acid)IBA
01/2017 - 10/2002
2Hormones (Hormone)IBA
11/2014 - 09/2011
2Phenobarbital (Luminal)FDA Link
01/2013 - 03/2012
2Glucose (Dextrose)FDA LinkGeneric
12/2008 - 08/2008
2LipidsIBA
12/2008 - 08/2008
2Enterotoxin ReceptorsIBA
04/2007 - 12/2006
2Factor VII (Proconvertin)IBA
03/2003 - 12/2002
1Histone MethyltransferasesIBA
01/2022
1Cytotoxins (Cytolysins)IBA
01/2022
1Nonsense Codon (Nonsense Mutation)IBA
06/2021
1Interleukin-12 (IL 12)IBA
10/2020
1InterferonsIBA
10/2020
1palbociclibIBA
01/2020
1snake venom protein C activatorIBA
01/2020
1Cyclin-Dependent Kinase 4IBA
01/2020
1GlucocorticoidsIBA
01/2020
1Interleukin-7 (Interleukin 7)IBA
01/2020
1SteroidsIBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1Proteolysis Targeting ChimeraIBA
01/2020
1histone H3 trimethyl Lys4IBA
01/2020
1S100A12 ProteinIBA
12/2019
1Messenger RNA (mRNA)IBA
12/2019
1InterleukinsIBA
01/2019
1vorapaxarIBA
01/2018
1protease-activated receptor 4IBA
01/2018
1TetraspaninsIBA
01/2018
1Imatinib Mesylate (Gleevec)FDA Link
01/2018
1Estrogen Receptor alphaIBA
10/2017
1Histones (Histone)IBA
01/2017
1Collagen Type VIIIBA
01/2017
1Deoxyribonucleases (DNase)FDA Link
01/2017
1Complement System Proteins (Complement)IBA
01/2017
1Nucleic AcidsIBA
01/2016
1Tyrosine (L-Tyrosine)FDA Link
08/2015
1Small Interfering RNA (siRNA)IBA
11/2014
1LipopolysaccharidesIBA
08/2014
1dabrafenibIBA
12/2013
1Mitogen-Activated Protein KinasesIBA
12/2013
1VemurafenibIBA
12/2013

Therapy/Procedure

20Therapeutics
06/2021 - 12/2006
2Drug Therapy (Chemotherapy)
01/2022 - 01/2018
2Radiotherapy
11/2014 - 09/2011
1Lab-On-A-Chip Devices
01/2016
1Aftercare (After-Treatment)
11/2014